Shenzhen Kangtai Biological Products (Chinese: 深圳康泰生物制品股份有限公司, SZSE: 300601), also known as BioKangtai (Chinese: 康泰生物), is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products. Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China.
Property | Value |
---|---|
dbo:abstract |
|
dbo:foundingDate |
|
dbo:foundingYear |
|
dbo:headquarter | |
dbo:locationCity | |
dbo:numberOfEmployees |
|
dbo:type | |
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink |
|
dbp:founded |
|
dbp:founder |
|
dbp:hqLocation |
|
dbp:hqLocationCity | |
dbp:hqLocationCountry |
|
dbp:name |
|
dbp:numEmployees |
|
dbp:type | |
dbp:wikiPageUsesTemplate | |
dcterms:subject |
|
georss:point |
|
rdf:type | |
rdfs:comment |
|
rdfs:label |
|
owl:sameAs | |
geo:geometry |
|
geo:lat |
|
geo:long |
|
prov:wasDerivedFrom | |
foaf:isPrimaryTopicOf | |
foaf:name |
|
is dbo:wikiPageWikiLink of | |
is foaf:primaryTopic of |